95.03
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$95.34
Aprire:
$95.2
Volume 24 ore:
3.24M
Relative Volume:
0.47
Capitalizzazione di mercato:
$121.89B
Reddito:
$34.20B
Utile/perdita netta:
$4.69B
Rapporto P/E:
26.24
EPS:
3.6218
Flusso di cassa netto:
$5.30B
1 W Prestazione:
-1.52%
1M Prestazione:
+0.89%
6M Prestazione:
+14.91%
1 anno Prestazione:
+5.60%
Medtronic Plc Stock (MDT) Company Profile
Nome
Medtronic Plc
Settore
Industria
Telefono
01135314381700
Indirizzo
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Confronta MDT con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MDT
Medtronic Plc
|
95.03 | 123.83B | 34.20B | 4.69B | 5.30B | 3.6218 |
![]()
ABT
Abbott Laboratories
|
127.62 | 231.95B | 43.11B | 13.94B | 6.78B | 7.9963 |
![]()
BSX
Boston Scientific Corp
|
97.78 | 142.60B | 18.49B | 2.50B | 3.49B | 1.6801 |
![]()
SYK
Stryker Corp
|
369.25 | 141.45B | 23.82B | 2.92B | 4.02B | 7.5574 |
![]()
EW
Edwards Lifesciences Corp
|
72.64 | 43.07B | 5.69B | 1.41B | 577.90M | 6.9828 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-06-30 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
2025-06-16 | Iniziato | Leerink Partners | Outperform |
2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
2024-10-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2024-08-21 | Reiterato | Oppenheimer | Perform |
2024-08-15 | Aggiornamento | UBS | Sell → Neutral |
2024-08-14 | Downgrade | Stifel | Buy → Hold |
2024-05-30 | Iniziato | Goldman | Sell |
2023-07-19 | Iniziato | Robert W. Baird | Neutral |
2023-06-30 | Iniziato | CL King | Buy |
2023-05-30 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2023-04-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2023-03-29 | Downgrade | UBS | Buy → Sell |
2023-01-09 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2022-11-23 | Downgrade | Citigroup | Buy → Neutral |
2022-11-23 | Downgrade | Oppenheimer | Outperform → Perform |
2022-11-16 | Downgrade | Deutsche Bank | Buy → Hold |
2022-10-18 | Iniziato | Barclays | Equal Weight |
2022-10-13 | Iniziato | Mizuho | Buy |
2022-10-12 | Iniziato | Jefferies | Hold |
2022-08-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
2022-07-06 | Iniziato | Wolfe Research | Underperform |
2022-06-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
2022-05-27 | Downgrade | Needham | Buy → Hold |
2022-04-13 | Downgrade | Truist | Buy → Hold |
2022-03-02 | Ripresa | BofA Securities | Buy |
2022-01-10 | Downgrade | BTIG Research | Buy → Neutral |
2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
2021-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
2021-12-16 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
2021-06-10 | Ripresa | Cowen | Outperform |
2021-05-25 | Iniziato | Barclays | Equal Weight |
2021-04-15 | Iniziato | Atlantic Equities | Overweight |
2020-12-15 | Aggiornamento | Goldman | Sell → Neutral |
2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2020-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
2020-10-08 | Aggiornamento | Stifel | Hold → Buy |
2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
2020-05-14 | Downgrade | DZ Bank | Buy → Hold |
2020-03-30 | Downgrade | Needham | Strong Buy → Buy |
2020-03-25 | Aggiornamento | DZ Bank | Hold → Buy |
2020-03-05 | Iniziato | Citigroup | Buy |
2020-02-13 | Iniziato | Goldman | Sell |
2020-01-08 | Iniziato | SunTrust | Buy |
2020-01-02 | Aggiornamento | Guggenheim | Neutral → Buy |
2019-06-05 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
2019-02-04 | Reiterato | Needham | Strong Buy |
2019-01-03 | Iniziato | Deutsche Bank | Buy |
2019-01-02 | Downgrade | Citigroup | Buy → Neutral |
2018-12-19 | Aggiornamento | JP Morgan | Neutral → Overweight |
2018-11-28 | Iniziato | UBS | Buy |
2018-10-16 | Iniziato | Barclays | Overweight |
2018-08-27 | Reiterato | Argus | Buy |
Mostra tutto
Medtronic Plc Borsa (MDT) Ultime notizie
Global Smart Medical Devices Market Poised to Expand at a CAGR of ~12% with Technological Advancements and Increased Adoption | DelveInsight - GlobeNewswire Inc.
Medtronic Launches Avalus Ultra™ Surgical Valves In India, Enhancing Cardiac Care For Patients. - TRIPURA STAR NEWS
Truist Securities Raises Medtronic (MDT) Price Target to $103 | MDT Stock News - GuruFocus
Why Medtronic (MDT) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Baird Adjusts Medtronic Price Target to $103 From $96, Maintains Neutral Rating - MarketScreener
Medtronic launches Avalus Ultra surgical valves in India, enhancing cardiac care for patients - The Hans India
Tools to monitor Medtronic plc recovery probability2025 Technical Patterns & Risk Adjusted Swing Trade Ideas - newser.com
Is Medtronic plc stock ready for a breakoutJuly 2025 Fed Impact & High Accuracy Investment Signals - newser.com
Medtronic launches next-gen Avalus Ultra heart valve in India - MassDevice
Medtronic launches Avalus Ultra™ surgical valves in India - BioSpectrum India
Why Medtronic (MDT) is a Top Value Stock for the Long-Term - Yahoo Finance
Leerink Partners Adjusts Price Target on Medtronic to $114 From $111, Maintains Outperform Rating - MarketScreener
Mizuho Adjusts Price Target on Medtronic to $115 From $100, Maintains Outperform Rating - MarketScreener
How Medtronic Plc. (MDT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
How Medtronic’s (MDT) R&D and Emerging Market Strategy Drive its Dividend Success - Yahoo Finance
Medtronic Stent Graft System Receives FDA Labeling Approval to Remove rAAA Treatment Warning - Diagnostic and Interventional Cardiology
Medtronic earns first-of-its-kind FDA labeling for Endurant stent graft - MassDevice
Medtronic Hugo robotic IDE trial targets gynaecology surgery precision and outcomes - Medical Device Network
Verdence Capital Advisors LLC Has $2.56 Million Stock Position in Medtronic PLC $MDT - MarketBeat
Atria Wealth Solutions Inc. Decreases Stake in Medtronic PLC $MDT - MarketBeat
Yousif Capital Management LLC Lowers Stake in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Bought by Vest Financial LLC - MarketBeat
Medtronic PLC $MDT Shares Acquired by Pzena Investment Management LLC - MarketBeat
Leith Wheeler Investment Counsel Ltd. Has $30.13 Million Holdings in Medtronic PLC $MDT - MarketBeat
Stack Financial Management Inc Sells 2,987 Shares of Medtronic PLC $MDT - MarketBeat
Meritage Portfolio Management Sells 2,676 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Bought by Vanguard Personalized Indexing Management LLC - MarketBeat
Medtronic Plc (MDT) Stock Analysis: Exploring Growth Potential And Dividend Stability - DirectorsTalk Interviews
Medtronic plc (MDT): Among Stocks to Buy from Dividend Stock Portfolio For Income - MSN
Medtronic plc stock trend forecastInsider Selling & Reliable Breakout Forecasts - newser.com
Brightwater Advisory LLC Acquires 2,673 Shares of Medtronic PLC $MDT - MarketBeat
Cerro Pacific Wealth Advisors LLC Buys 4,406 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Bought by Johnson Investment Counsel Inc. - MarketBeat
Medtronic PLC $MDT is Matrix Asset Advisors Inc. NY's 8th Largest Position - MarketBeat
Fifth Third Wealth Advisors LLC Has $1.98 Million Stock Holdings in Medtronic PLC $MDT - MarketBeat
Callan Family Office LLC Boosts Holdings in Medtronic PLC $MDT - MarketBeat
Precision Trading with Medtronic Plc. (MDT) Risk Zones - news.stocktradersdaily.com
JB Capital LLC Buys 6,515 Shares of Medtronic PLC $MDT - MarketBeat
Drucker Wealth 3.0 LLC Has $2.61 Million Holdings in Medtronic PLC $MDT - MarketBeat
Aberdeen Group plc Purchases 27,470 Shares of Medtronic PLC $MDT - MarketBeat
Venturi Wealth Management LLC Sells 4,008 Shares of Medtronic PLC $MDT - MarketBeat
Intuitive’s challengers continue to advance - MedTech Dive
TIME Best Invention Honor Granted to Medtronic’s Adaptive Deep Brain Stimulation Tech - Medical Product Outsourcing
RBC Raises Price Target on Medtronic to $111 From $103, Keeps Outperform Rating - MarketScreener
Medtronic (NYSE:MDT) Receives "Buy (B-)" Rating from Weiss Ratings - MarketBeat
US Bancorp DE Sells 97,898 Shares of Medtronic PLC $MDT - MarketBeat
Insight Inv LLC Cuts Stock Position in Medtronic PLC $MDT - MarketBeat
Columbus Macro LLC Purchases 13,416 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Sold by Leo Wealth LLC - MarketBeat
Medtronic PLC $MDT Holdings Decreased by Tectonic Advisors LLC - MarketBeat
Prime Capital Investment Advisors LLC Has $933,000 Stock Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic Plc Azioni (MDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):